Dechra Pharmaceuticals PLC, has acquired a canine lymphoma drug from Pet health tech firm, Anivive Lifesciences. The therapy, Laverdia™-CA1 (verdinexor), is the first of its kind, according to the...
Pet health technology company, Anivive Lifesciences Inc., has been awarded a grant from FDA for $500,000. The company will commit the funding to continued studies on canine lymphoma treatment with...
